In contrast, PCK1 is upregulated and oncogenic in tumors originating from non-gluconeogenic organs (CRC, lung cancer, melanoma, breast cancer, pancreatic cancer, and gastric cancer). This evidence concerns the gene PCK1 and lung carcinoma.